Reimbursement Established for Lung and Liver Transplant in the Netherlands Based on Results from Clinical Trials with XVIVO’s Leading Technologies

Machine perfusion for lungs and livers is being reimbursed in the Dutch healthcare system. The Netherlands has a pronounced evidence-based healthcare system. Therefore, if a treatment option is proven beneficial for patients the government is likely to approve reimbursement.
[BioSpace]
Press Release
spot_img

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News